Short description
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Description
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.The company's therapies deliver nucleic acids and other molecules to skeletal, cardiac and smooth muscle with unprecedented precision, enabling patients to restore muscle strength and transform their lives.
Last funding
Noaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Cambridge, Massachusetts, United States, North America
Founded on
January 1, 2018
Exited on
September 16, 2020
Went public on
September 16, 2020
Stock symbol
DYN
Non-profit?
No
Acquired?
No
Employees count
101-250
Investors
Noaccess, Noway Youcantaccess, Noaccess, No Way, Cannot Access, Uh Ohhhh, Noaccess, Cannot Access, Nopepepe
Sign in for full access
Founders
Phillip Samayoa, Romesh Subramanian